D-0574-2016 Class III Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

FDA drug recall D-0574-2016 was initiated by PD-Rx Pharmaceuticals, Inc. on Jul 21, 2015 and is designated Class III. Reason for recall: Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station The recall status is terminated (terminated Dec 23, 2016). Affected quantity: 1685 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 27, 2016
Initiation Date
Jul 21, 2015
Termination Date
Dec 23, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1685 bottles

Product description

Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 7-count (NDC 55289-791-07), b) 14-count (NDC 55289-791-14), c) 28-count (NDC 55289-791-28), d) 30-count (NDC 55289-791-30), and e) 60-count (NDC 55289-791-60) bottles, Packaged by PD-RX Pharmaceuticals, INC Oklahoma City, OK 73127, MFG: KVK-TECH, INC Newtown, PA 18840.

Reason for recall

Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station

Distribution pattern

Nationwide

Code information

Lot #: a) H14C80, Exp 08/16; I14G36, Exp 09/16; b) H14A86, Exp 07/16; c) H14C83, Exp 08/16, K14A21, Exp 11/16; d) H14F25, Exp 08/16; e) L14C42, Exp 12/16.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0574-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0574-2016. Report a data issue: hello@regdatalab.com.